Selective inhibition of T follicular helper cells for treatment of autoimmune disorders

METHODS AND COMPOSITIONS OF RNA NANOSTRUCTURES FOR REPLICATION AND SUB-GENOMIC EXPRESSION BY RNA-DIRECTED RNA POLYMERASE

COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS TO CELLS

LIPID CONJUGATES FOR THE DELIVERY OF THERAPEUTIC AGENTS

METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS

METHODS OF USING ZSCAN4 FOR REJUVENATING HUMAN CELLS

COMPOSITIONS AND METHODS FOR INHIBITING NUCLEAR RECEPTOR SUBFAMILY 1 GROUP H MEMBER 3 (NR1H3) EXPRESSION

Transmembrane protease, serine 6 (TMPRSS6) iRNA compositions and methods of use thereof

METHODS AND MODIFICATIONS THAT PRODUCE ssRNAi COMPOUNDS WITH ENHANCED ACTIVITY, POTENCY AND DURATION OF EFFECT

CILP-1 Inhibitors for Use in the Treatment of Dilated Cardiomyopathies

MULTIMERIC OLIGONUCLEOTIDES WITH DIVIDED STRANDS

D-SERINE TRANSPORT MODIFIER AND SCREENING METHOD THEREOF, AND SCREENING METHOD OF D-SERINE TRANSPORTER PROTEIN

OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF

GENE-REGULATING COMPOSITIONS AND METHODS FOR IMPROVED IMMUNOTHERAPY

METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA DIRECTED MODULATION OF TRANSCRIPTION

Cellular Ablation of HLA-Class I MHC

MEDICAMENT USED FOR TREATING CHOLANGIOCARCINOMA WITH KRAS MUTATIONS

COMPOSITIONS AND METHODS OF INDUCING RNAI OR TYPE I IFN COMPETENT CELLS AND USES THEREOF

COMPOSITIONS AND METHODS FOR TREATING HYPERTRIGLYCERIDEMIA

MAPT RNA INTERFERENCE AGENTS

EDIBLE PLANT EXOSOME-LIKE NANOVECTORS FOR VACCINATION

NUCLEIC ACID MOLECULES FOR REDUCTION OF PAPD5 OR PAPD7 MRNA FOR TREATING HEPATITIS B INFECTION

RNAi FOR CONTROL OF PHLOEM SAP-FEEDING INSECTS IN CROP PLANTS

GENETIC MODIFICATION OF MAMMALIAN CELLS TO CONFER RESISTANCE TO CSF1R ANTAGONISTS

SYSTEMS AND METHODS FOR TREATING LEVODOPA DYSKINESIA, ENHANCING MOTOR BENEFIT, AND DELAYING DISEASE PROGRESSION

DYNAMIN 2 INHIBITOR FOR THE TREATMENT OF CENTRONUCLEAR MYOPATHIES

FIDGETIN-LIKE 2 AS A TARGET TO ENHANCE SKIN GRAFT HEALING

AMPHIREGULIN GENE-SPECIFIC DOUBLE-STRANDED OLIGONUCLEOTIDE AND COMPOSITION FOR PREVENTING AND TREATING FIBROSIS-RELATED DISEASES AND RESPIRATORY DISEASES, COMPRISING SAME

Biomarkers Related to Oral Squamous Cell Carcinoma and Methods of Diagnosis and Treatment Thereof

DOUBLE-STRANDED OLIGONUCLEOTIDE AND COMPOSITION FOR TREATING COVID-19 CONTAINING SAME

UTILIZING RNA INTERFERENCE AGAINST SARS-COV-2

COMPOSITIONS AND METHODS FOR CONTROLLING LEPTINOTARSA

EXOSOME-DERIVED PIWI-INTERACTING RNA AND METHODS OF USE THEREOF

MICROTUBULE ASSOCIATED PROTEIN TAU (MAPT) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF

DOUBLE STRANDED OLIGONUCLEOTIDE COMPOSITIONS AND METHODS RELATING THERETO

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR MODULATION OF GENES ASSOCIATED WITH MUSCLE HEALTH

PREPARATION METHOD OF ARTIFICIAL ANTIBODY

MULTI-CONJUGATES COMPRISING MULTIPLE LIGANDS

SYNTHESIS OF 3'N NUCLEOSIDES THROUGH OXIME INTERMEDIATES AND RELATED COMPOUNDS

Compositions and methods of treating muscle atrophy and myotonic dystrophy

Compositions and methods of treating muscle atrophy and myotonic dystrophy

LINKER COMPOUNDS

MODULATORS OF FOXP3 EXPRESSION

TRANSMEMBRANE SERINE PROTEASE 2 (TMPRSS2) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

COMPOSITION FOR PREVENTING OR TREATING DISEASE CAUSED BY MUSCLE LOSS, COMPRISING AGENT INHIBITING PHF20

OLIGONUCLEOTIDES FOR SOD1 MODULATION

MULTI-TARGETED siRNA FOR TREATING CANCERS

NUCLEIC ACID, PHARMACEUTICAL COMPOSITION, CONJUGATE, PREPARATION METHOD, AND USE

Composition of drug targets and method of using thereof

APOLIPOPROTEIN E (APOE) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF

CARDIAC CELL PROLIFERATION BY ADMINISTERING INHIBITORS OF SAV1, NF2, MOB1 AND/OR MUTANT SRF

COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER

METHODS FOR THE DIAGNOSIS AND TREATMENT OF CYTOKINE RELEASE SYNDROME

Human antibodies to the human glucagon receptor (HGCGR) and methods of use thereof to lower blood glucose or ketone levels

RECOMBINANT POLYPEPTIDES FOR MEMBRANE FUSION AND USES THEREOF

Treating metastatic cancer and model systems for metastatic disease

METHODS FOR TREATING GAIN-OF-FUNCTION DISORDERS COMBINING GENE EDITING AND GENE THERAPY

COMPOSITIONS AND METHODS FOR THE TREATMENT OF A BETA-CATENIN-ASSOCIATED DISEASE OR DISORDER

COMPOSITIONS AND METHODS FOR FUNGAL INHIBITION USING MINICELL-BASED RNAi

COMPOSITIONS FOR TRANSFER OF CARGO TO CELLS

COMPOSITIONS AND METHODS FOR INHIBITING MARC1 GENE EXPRESSION

PRODUCTS FOR SUPPRESSING OR REDUCING THE EXPRESSION OR ACTIVITY OF A SNORNA AND USES THEREOF IN THE TREATMENT OF CANCER

Modified double-stranded RNA agents

COMPOSITIONS AND METHODS FOR THE DELIVERY OF AGENTS TO BIOLOGICAL TARGETS

COMPOSITIONS AND METHODS FOR TREATING NEOPLASIA

Hybridosomes, compositions comprising the same, processes for their production and uses thereof

IMMUNOLOGICALLY COMPATIBLE AND REVERSIBLE UNIVERSAL PLURIPOTENT STEM CELL AND APPLICATION THEREOF

METHODS FOR INDUCING BILE ACID SULFOTRANSFERASE SULT2A FOR TREATING METABOLIC DISORDERS

Medication and diagnostic kit for inhibiting metastasis and invasion of breast cancer, shRNA molecule for silencing expression of human LINC01614 and application thereof

METHODS AND COMPOSITIONS FOR MODULATING GENE EXPRESSION

TARGETED ANTIVIRAL DRUGS

DEPLETION OF EXT1 EXPRESSION AND/OR ACTIVITY IMPROVES CELLULAR PRODUCTION OF BIOLOGICAL ENTITIES

COMPOUNDS AND METHODS FOR REDUCING PSD3 EXPRESSION

COMPOSITIONS AND METHODS FOR INTRANASAL TREATMENT WITH DOUBLE STRANDED RNA

METHOD OF STIMULATING PROLIFERATION OF A CELL

COMPOSITIONS AND METHODS FOR SILENCING SCN9A EXPRESSION

TARGETING THE PALMOTYLATION/DEPALMOTYLATION CYCLE TO TREAT INFLAMMATORY DISEASES

MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA) MOLECULES AND USES THEREOF

USE OF LNCRNA XR_595534.2 IN PREPARATION OF MEDICINE FOR TREATMENT OR PREVENTION OF CHRONIC PAIN

Composition for preventing or treating diseases caused by overexpression of chemokine CXCL1, containing death receptor inhibitor as active ingredient

EXPRESSION OF FC-CONTAINING PROTEINS

COMPOUND COMPRISING A NUCLEIC ACID AND A HALF-LIFE EXTENSION MOTIF

Prekallikrein-modulating compositions and methods of use thereof

METHODS AND COMPOSITIONS FOR APTAMER-DRIVEN SURFACE FORMULATION OF SELF-FORMING POLYNUCLEOTIDE NANOPARTICLES

COMPOSITIONS AND METHODS FOR INHIBITING TDP-43 AND FUS AGGREGATION

EXTRACELLULAR VESICLE SECRETION REDUCING AGENT FOR REDUCING EXTRACELLULAR VESICLE SECRETION, AND USE OF THE SAME

MODIFIED SHORT-INTERFERING RNA COMPOSITIONS AND THEIR USE IN THE TREATMENT OF CANCER

ARTC1 LIGANDS FOR CANCER TREATMENT

COMPOSITIONS AND METHODS OF MODULATING B CELL RESPONSE

TREATMENT OF ALT CANCERS

METHODS FOR ENHANCING VASCULAR DENSITY

DESIGN METHOD FOR OPTIMIZED RIG-I LIGANDS

MULTIMERIC OLIGONUCLEOTIDES WITH DIVIDED STRANDS

TREATMENT OF COVID-19 WITH REVERSE MICELLE SYSTEM COMPRISING UNMODIFIED OLIGONUCLEOTIDES

SYSTEMIC DELIVERY OF MYOSTATIN SHORT INTERFERING NUCLEIC ACIDS (SINA) CONJUGATED TO A LIPOPHILIC MOIETY

METHOD FOR TREATING CARDIOVASCULAR DISEASE

METHODS AND COMPOSITIONS FOR INACTIVATING INTERLEUKIN-2-INDUCIBLE T-CELL KINASE (ITK)

SiRNA molecule inhibiting the expression of the PCSK9 gene and use thereof

RNAi Agents for Inhibiting Expression of Xanthine Dehydrogenase (XDH), Pharmaceutical Compositions Thereof, and Methods of Use

1'-ALKYL MODIFIED RIBOSE DERIVATIVES AND METHODS OF USE

ALPHA-2A ADRENERGIC RECEPTOR (ADRA2A) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF

GENE SILENCING AGENTS FOR TARGETING CORONAVIRUS GENES AND USES THEREOF

COMPOSITIONS AND METHODS FOR SILENCING VEGF-A EXPRESSION

PRODUCTS AND COMPOSITIONS

ANGIOPOIETIN-LIKE 3 (ANGPTL3) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

DOUBLE-STRANDED OLIGONUCLEOTIDE, COMPOSITION AND CONJUGATE COMPRISING DOUBLE-STRANDED OLIGONUCLEOTIDE, PREPARATION METHOD THEREOF AND USE THEREOF

USE OF CDON INHIBITORS FOR THE TREATMENT OF ENDOTHELIAL DYSFUNCTION

METHODS OF ATTENUATING AN IMMUNE RESPONSE BY INHIBITION OF BFL1

TREATMENT OF COVID-19 WITH REVERSE MICELLE SYSTEM COMPRISING UNMODIFIED OLIGONUCLEOTIDES

Fc FRAGMENT OF IgG RECEPTOR AND TRANSPORTER (FCGRT) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

LEUCINE-RICH REPEAT KINASE 2 (LRRK2) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF

MANNAN BINDING LECTIN SERINE PEPTIDASE 2 (MASP2) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

RNAi Agents for Inhibiting Expression of Xanthine Dehydrogenase (XDH), Pharmaceutical Compositions Thereof, and Methods of Use

Composition for preventing or treating keloids or hypertrophic scars

4'-O-METHYLENE PHOSPHONATE NUCLEIC ACIDS AND ANALOGUES THEREOF

RNA-DIRECTED DNA CLEAVAGE BY THE Cas9-crRNA COMPLEX

Deaminase-based RNA sensors

ANGIOTENSINOGEN (AGT) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

METHODS AND COMPOSITIONS FOR TREATMENT OF ATHEROSCLEROSIS

USP10 TARGETED SELF-DELIVERABLE SIRNA COMPOSITIONS AND METHODS FOR PREVENTING OR INHIBITING FIBROSIS AND/OR SCARRING

USE OF COPS3 INHIBITORS FOR TREATING HEPATITIS B VIRUS INFECTION

CHIRALLY-ENRICHED DOUBLE-STRANDED RNA AGENTS

COMPOSITIONS AND METHODS FOR INHIBITION OF HAO1 (HYDROXYACID OXIDASE 1 (GLYCOLATE OXIDASE)) GENE EXPRESSION

Immunomodulatory RNA

DIAGNOSTIC METHODS USING PCG-1A EXPRESSION

HYPERBRANCHED POLYMERS AND POLYPLEXES AND DNA OR RNA DELIVERY SYSTEMS INCLUDING THE SAME

USE OF SARAF INHIBITORS FOR TREATING HEPATITIS B VIRUS INFECTION

RNAI INDUCED HUNTINGTIN GENE SUPPRESSION

Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy

USE OF SCAMP3 INHIBITORS FOR TREATING HEPATITIS B VIRUS INFECTION

MUSCLE-TARGETING COMPLEXES AND USES THEREOF IN TREATING MUSCLE ATROPHY

NANOPARTICLES FOR EXPRESSION OF GENES OF INTEREST AND/OR REGULATION OF SIGNALING PATHWAYS

HUMAN CHROMOSOME 9 OPEN READING FRAME 72 (C9ORF72) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF

SYNTHETIC PROCESSES AND INTERMEDIATES

Methods Of Treating Clonal Hematopoiesis Of Indeterminate Potential (CHIP) With Lymphocyte Antigen 75 (LY75), Cluster Of Differentiation 164 (CD164), Or Poly(ADP-Ribose) Polymerase 1 (PARP1) Inhibitors

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF KRAS BY ASYMMETRIC DOUBLE-STRANDED RNA

MODIFIED DOUBLE-STRANDED RNA AGENTS

Targeted compositions

Compound and application thereof

TRIALKYL CATIONIC LIPIDS AND METHODS OF USE THEREOF

METHODS FOR REDUCING HTT EXPRESSION

COMPOSITIONS AND METHODS FOR INHIBITING ALPHA-1 ANTITRYPSIN EXPRESSION

POLY(BETA-AMINO ESTER)-CO-POLYETHYLENE GLYCOL (PEG-PBAE-PEG) POLYMERS FOR GENE AND DRUG DELIVERY

Methods Of Treating Chronic Kidney Disease (CKD) With Inhibitors Of Protective Loss-Of-Function Genes

METHODS AND COMPOSITIONS FOR TREATING A PROPROTEIN CONVERTASE SUBTILISIN KEXIN (PCSK9) GENE-ASSOCIATED DISORDER

OVERLAPPING THERAPEUTIC STRATEGIES FOR CYSTINOSIS TREATMENT AND COSMETIC SKIN DARKENING

KISSPEPTIN 1 (KISS1) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

Increasing gene expression

Compositions comprising reversibly modified oligonucleotides and uses thereof

Cancer treatment using siRNA to modulate expression of PRDM2/RIZ protein

Treatment Of Glaucoma With Rho Guanine Nucleotide Exchange Factor 12 (ARHGEF12) Inhibitors

SERINE PROTEASE INHIBITORS FOR SUPPRESSING OR PREVENTING ANAPHYLACTIC REACTION

VITAMIN B6-COUPLED POLYOL-BASED POLYDIXYLITOL GENE TRANSPORTER COMPRISING PEPTIDE BINDING SPECIFICALLY TO CANCER STEM CELL AND CANCER STEM CELL-TARGETED THERAPY TECHNIQUE

ANTI-ADAM33 OLIGONUCLEOTIDES AND RELATED METHODS

STEROL REGULATORY ELEMENT BINDING PROTEIN (SREBP) CHAPERONE (SCAP) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

Compositions and methods for delivery of nucleic acids to cells

Methods of treating cancers having a BRCA1 and/or BRCA2 mutation(s)

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSING OF METHYLATION-CONTROLLED J-PROTEIN (MCJ)

PRODUCTS AND COMPOSITIONS

CHEMICALLY MODIFIED OLIGONUCLEOTIDES WITH IMPROVED SYSTEMIC DELIVERY

Targeted therapy composition and its use for suppressing breast cancer cell proliferation, migration or invasion

TOPICAL DELIVERY OF RNA INTERFERENCE AGENTS USING IONIC LIQUID

Compositions and methods for delivery of nucleic acids to cells

Adeno-associated virus for activating RNA-NEAT1 over-expression and applications thereof

DRUG FOR CURATIVE THERAPY OF INTRACTABLE HEREDITARY RENAL ALPORT SYNDROME

ANTICANCER ADJUVANT AND PHARMACEUTICAL COMPOSITION FOR TREATING ANTICANCER-AGENT-RESISTANT CANCER, AND KIT COMPRISING SAME

METHODS AND MATERIALS FOR TREATING CANCER

Methods and compositions for reducing pathogenic isoforms

COMPOSITIONS COMPRISING BACTERIALLY DERIVED MINICELLS AND METHODS OF USING THE SAME

RNAi CONSTRUCTS AND METHODS FOR INHIBITING LPA EXPRESSION

COMPOSITIONS AND METHODS FOR TREATING OR AMELIORATING A MYCOBACTERIUM TUBERCULOSIS INFECTION

Composition for preventing or treating cognitive dysfunction including inhibitor or MECP2 expression

VECTORIZED ANTIBODIES (vAb) AND USES THEREOF

Treatment Of Inflammatory Diseases With RAS Protein Activator Like 3 (RASAL3) Inhibitors

TREATMENT OF THYMIC STROMAL LYMPHOPOIETIN (TSLP) RELATED DISEASES BY INHIBITION OF LONG-FORM TSLP TRANSCRIPTS

THERAPY OF RAS-DEPENDENT CANCERS

REPROGRAMMING THE METABOLOME TO DELAY ONSET OR TREAT NEURODEGENERATION

Multi-conjugate of siRNA and preparing method thereof

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF ALPHA-1 ANTITRYPSIN BY DOUBLE-STRANDED RNA

APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

Methods and compositions for genomic integration

METHODS AND COMPOSITIONS FOR INDUCING APOPTOSIS IN CANCER STEM CELLS

ANTAGONISM AS A THERAPY FOR TDP-43 PROTEINOPATHIES

METHODS AND USES FOR PROPROTEIN CONVERTASE SUBTILISIN KEXIN 9 (PCSK9) INHIBITORS

TARGETED AND LOCALIZED IN VIVO DELIVERY OF OLIGONUCLEOTIDES

4′-phosphate analogs and oligonucleotides comprising the same

RIBONUCLEOPROTEINS FOR RNA THERAPEUTICS DELIVERY AND GENE SILENCING

FORMULATIONS FOR DELIVERY OF OLIGONUCLEOTIDES TO LUNG CELLS

Modulation Of Endoplasmic Reticulum Aminopeptidase 2 (ERAP2)-Mediated Immune Response

Methods and compositions for the specific inhibition of transthyretin (TTR) by double-stranded RNA

INHIBITION OF TAP63 REGULATED ONCOGENIC LONG NON-CODING RNAS (TROLLS) IN THE TREATMENT OF CANCER

METHODS AND COMPOSITIONS FOR THE INHIBITION OF HEPATITIS B AND HEPATITIS D VIRUS INFECTIONS

ATAXIN3 (ATXN3) RNAI AGENT COMPOSITIONS AND METHODS OF USE THEREOF

NOVEL PRECURSOR MIRNA AND APPLICATION THEREOF IN TUMOR TREATMENT

Methods of treating decreased bone mineral density with cluster of differentiation 109 (CD109) inhibitors

COMPOUNDS AND METHODS FOR REDUCING APP EXPRESSION

INHIBITION OF DENND5B EXPRESSION FOR TREATING HEPATIC STEATOSIS

METHODS AND COMPOSITIONS FOR MODULATING GENE EXPRESSION

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF MUTANT EGFR GENE

USE OF POTASSIUM CHANNEL INHIBITOR FOR TREATING DEPRESSION

MODIFIED DOUBLE STRANDED OLIGONUCLEOTIDE

PLATELETS TRANSFECTED BY EXOGENOUS GENETIC MATERIAL AND PLATELET MICROPARTICLES OBTAINED BY SAID TRANSFECTED PLATELETS, METHOD FOR THE PREPARATION AND USES THEREOF

COMPOSITIONS AND METHODS OF TREATMENT FOR LYTIC AND LYSOGENIC VIRUSES

COMPOSITIONS AND METHODS OF TREATING MUSCLE ATROPHY AND MYOTONIC DYSTROPHY

siRNA based on RNA sequence of SARS-CoV-2 and use thereof

System for the biocontrol of white spot syndrome virus (WSSV) in aquaculture

TREATMENT OF PROGRESSIVE SUPRANUCLEAR PALSY

Muscle targeting complexes and uses thereof for treating Facioscapulohumeral muscular dystrophy

METHODS AND COMPOSITIONS FOR TREATING ATHEROSCLEROSIS

CTGF GENE-SPECIFIC DOUBLE-STRANDED OLIGONUCLEOTIDE, AND A COMPOSITION FOR PREVENTING AND TREATING FIBROTIC DISEASES AND RESPIRATORY-RELATED DISEASES COMPRISING SAME

Compositions and methods for inhibiting mitochondria amidoxime reducing component 1 (MARC1) expression

ADOPTIVE CELL THERAPY WITH ZBTB20 SUPPRESSION

Methods and Compositions for Modulationg Heterochromatin Dysfunction, Genomic Instability, and Associate Conditions

METHOD FOR TREATING ANGELMAN SYNDROME AND RELATED DISORDERS

COMPOSITIONS AND METHODS FOR SILENCING DNAJB1-PRKACA FUSION GENE EXPRESSION

PERICYTE-SPARING THERAPY

PROCESS FOR BUILDING NANOPARTICLE-BASED DRUG CARRIERS VIA PROTEIN CORONA MODULATION

Modified EC7 Cells Having Low Toxicity to Viral Production Payloads

INHIBITORS OF KDM5A FOR USE IN TREATMENT OF IDIOPATHIC INFLAMMATORY MYOPATHIES

Treatment Of Psoriasis With Interferon Induced Helicase C Domain 1 (IFIH1) Inhibitors

ENGINEERED IMMUNE CELLS WITH REDUCED TOXICITY AND USES THEREOF

Compositions and methods for treating cancer

Targeting cell tropism receptors to inhibit cytomegalovirus infection

Treatment Of Cognitive Impairment With Alpha-N-Acetylgalactosaminide Alpha-2,6-Sialyltransferase 5 (ST6GALNAC5) Inhibitors

Compositions and methods for delivery of nucleic acids to cells

HSD17B13 VARIANTS AND USES THEREOF

TARGETING GLIOBLASTOMA STEM CELLS THROUGH THE TLX-TET3 AXIS

RNA INTERFERENCE MEDIATED INHIBITION OF CATENIN (CADHERIN-ASSOCIATED PROTEIN), BETA 1 (CTNNB1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA)

METHODS AND COMPOSITIONS TO PROMOTING RETINAL REGENERATION USING PROX1 MIGRATION INHIBITOR AS ACTIVE INGREDIENT

Tunable Reversir™ compounds

MicroRNA (miRNA) and Downstream Targets for Diagnostic and Therapeutic Purposes

APOLIPOPROTEIN B ANTAGONIST

Treatment of Hypertension With Solute Carrier Family 9 Isoform A3 Regulatory Factor 2 (SLC9A3R2) Inhibitors

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE

Inhibitors of Cancer Biomarkers and Uses Thereof

Compositions and methods for organ specific delivery of nucleic acids

Compounds and methods for reducing IFNAR1 expression

Nucleic acids for inhibiting expression of C3 in a cell

NEUROFILAMENT LIGHT CHAIN (NFL) AS A BIOMARKER FOR TRANSTHYRETIN AMYLOIDOSIS POLYNEUROPATHY

NOVEL RNA THERAPEUTICS AND USES THEREOF

Transthyretin (TTR) iRNA compositions and methods of use thereof for treating or preventing TTR-associated diseases

USE OF GP73 INHIBITOR IN PREPARATION OF MEDICINE FOR TREATING DIABETES

Methods Of Treating Decreased Bone Mineral Density With Kringle Containing Transmembrane Protein 1 (KREMEN1) Inhibitors

Oligonucleotides for SARS-CoV-2 modulation

Methods for reactivating genes on the inactive X chromosome

COMPOUNDS AND METHODS FOR MODULATING C90RF72

Nucleic acids for inhibiting expression of PROS1 in a cell

INHIBITING THE RNA METHYLTRANSFERASE METTL3 OR ITS INTERACTION WITH EIF3H TO SUPPRESS ONCOGENE TRANSLATION AND TUMORIGENESIS

AN UBIQUITIN LIGASE INHIBITOR FOR USE FOR PREVENTING AND/OR TREATING A DISEASE LINKED WITH CEREBRAL HYPOPERFUSION

METHODS AND COMPOSITIONS TO INCREASE SOMATIC CELL NUCLEAR TRANSFER (SCNT) EFFICIENCY BY REMOVING HISTONE H3-LYSINE TRIMETHYLATION

EXOSOMES-BASED THERAPY FOR LIVER FIBROSIS AND OTHER DISEASES WITH FIBROSIS

RNAi agents for inhibiting expression of xanthine dehydrogenase (XDH), pharmaceutical compositions thereof, and methods of use

METHODS AND COMPOSTIONS FOR INHIBITING P97

NUCLEOSIDE DERIVATIVE AND USE THEREOF

TISSUE FOR USE AS ALLOGENEIC OR XENOGENEIC TRANSPLANT AND METHOD FOR ITS PRODUCTION

RNAI AGENTS, COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING TRANSTHYRETIN (TTR) ASSOCIATED DISEASES

COMBINATION THERAPY FOR C3 INHIBITION

METHOD OF TREATING CANCER AND METHOD OF SENSITIZING CANCER CELLS TO THE ACTION OF CHEMOTHERAPEUTIC AGENTS VIA GROWTH HORMONE RECEPTOR ANTAGONISTS OR KNOCK DOWN

METHODS AND COMPOSTIONS FOR INHIBITING CORONAVIRAL REPLICATION

RNAi agents for inhibiting expression of xanthine dehydrogenase (XDH), pharmaceutical compositions thereof, and methods of use

PCSK9 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

Compounds and methods for modulating factor XII

IL-34 ANTISENSE AGENTS AND METHODS OF USING SAME

Compositions and methods for inhibiting gene expression of alpha-1 antitrypsin

RNAi Agents for Inhibiting Expression of Mucin 5AC (MUC5AC), Compositions Thereof, and Methods of Use

CHEMICALLY MODIFIED OLIGONUCLEOTIDES TARGETING BROMODOMAIN CONTAINING PROTEIN 4 (BRD4) FOR IMMUNOTHERAPY

Vitro Cleavage of DNA Using Argonaute

SELECTIVE EXPANSION OF GENE-TARGETED CELLS

Muscle targeting complexes and uses thereof for treating dystrophinopathies

COMPOSITIONS AND METHODS FOR NUCLEIC ACID DELIVERY

Treatment Of Obesity With G-Protein Coupled Receptor 75 (GPR75) Inhibitors

PLATELETS TRANSFECTED BY EXOGENOUS GENETIC MATERIAL AND PLATELET MICROPARTICLES OBTAINED BY SAID TRANSFECTED PLATELETS, METHOD FOR THE PREPARATION AND USES THEREOF

METHODS AND COMPOSITIONS FOR GENOMIC INTEGRATION

METHODS OF CANCER TREATMENT BY DELIVERY OF siRNAs AGAINST NSD3

XANTHINE DEHYDROGENASE (XDH) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

RNA MOLECULE, CHIMERIC NA MOLECULE, DOUBLE-STRANDED RNA MOLECULE, AND DOUBLE-STRANDED CHIMERIC NA MOLECULE

Hippo and dystrophin complex signaling in cardiomyocyte renewal

Twist signaling inhibitor compositions and methods of using the same

NUCLEIC ACID COMPOSITIONS

Compositions and methods of treating muscle dystrophy

ENGINEERED T CELLS AND TUMOR-INFILTRATING LYMPHOCYTES TO OVERCOME IMMUNOSUPPRESSION IN THE TUMOR MICROENVIRONMENT

Control of plant pests using RNA molecules

COMPOSITION FOR INHIBITING GROWTH OF CANCER STEM CELLS, CONTAINING WDR34 INHIBITOR, AND USE THEREOF

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE

COMPLEMENT COMPONENT C5 IRNA COMPOSITIONS AND METHODS OF USE THEREOF

MODIFIED iRNA AGENTS

3' UTR CRISPR-DCAS 13 ENGINEERING SYSTEM AND METHODS OF USING SAME

Targeting Synaptogyrin-3 in Tauopathy Treatment

Trialkyne linking agents and methods of use

THERAPEUTIC INHIBITION OF LACTATE DEHYDROGENASE AND AGENTS THEREFOR

Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded RNA

RNAi Agents for Inhibiting Expression of Receptor for Advanced Glycation End-products, Compositions Thereof, and Methods of Use

TREATMENT OF COVID-19 LUNG INJURY USING UMBILICAL CORD PLASMA BASED COMPOSITIONS

CHEMICAL MODIFICATIONS OF SMALL INTERFERING RNA WITH MINIMAL FLUORINE CONTENT

COMPOSITIONS AND METHODS FOR SILENCING UGT1A1 GENE EXPRESSION

Nucleic acid, composition and conjugate comprising the same, and preparation method and use thereof

Modified double-stranded RNA agents

Compositions and methods of treatment

Compositions and methods for transport across the blood brain barrier

CONJUGATES AND METHODS FOR TREATING LIVER FIBROSIS